Skandinaviska Enskilda Banken AB (publ) - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$1,124,552
+77777.6%
98,300
-34.4%
0.01%
-22.2%
Q3 2023$1,444
-38.5%
149,900
-32.1%
0.01%
-40.0%
Q2 2023$2,349
+256.4%
220,800
+252.7%
0.02%
+200.0%
Q1 2023$659
-100.0%
62,600
-53.8%
0.01%
-54.5%
Q2 2022$1,562,000
-48.9%
135,500
-44.2%
0.01%
-38.9%
Q1 2022$3,054,000
-37.0%
242,800
-41.4%
0.02%
-28.0%
Q4 2021$4,850,000
-83.3%
414,500
-81.3%
0.02%
-84.3%
Q3 2021$28,998,000
+949.9%
2,220,400
+934.7%
0.16%
+835.3%
Q2 2021$2,762,000
+14.6%
214,600
-0.5%
0.02%
+6.2%
Q1 2021$2,410,000
-69.0%
215,600
-68.4%
0.02%
-69.8%
Q4 2020$7,778,000
+115.3%
682,900
+70.0%
0.05%
+103.8%
Q3 2020$3,612,000
+67.3%
401,600
+92.0%
0.03%
+52.9%
Q2 2020$2,159,000
+155.2%
209,200
+149.6%
0.02%
+325.0%
Q1 2020$846,000
-65.9%
83,800
-55.0%
0.00%
-78.9%
Q4 2019$2,478,000
+3.4%
186,200
-19.5%
0.02%
-9.5%
Q4 2018$2,397,000231,4000.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$191,107,00016.54%
HealthInvest Partners AB 730,000$8,512,00011.99%
13D Management LLC 612,853$7,146,0002.74%
Brown Capital Management 16,257,899$189,567,0001.57%
BRIDGER MANAGEMENT, LLC 929,714$10,840,0001.40%
Camber Capital Management LP 3,000,000$34,980,0001.20%
Intrinsic Value Partners, LLC 55,057$642,0000.68%
PRICE MICHAEL F 520,000$6,063,0000.67%
CLARK ESTATES INC/NY 355,000$4,139,0000.61%
WESTFIELD CAPITAL MANAGEMENT CO LP 8,145,674$94,979,0000.56%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders